FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: MENSTRUAL PRODUCTS-PERFORMANCE TESTING AND LABELING RECOMMENDATIONS; DRAFT GUIDANCE FOR INDUSTRY AND FOOD AND DRUG ADMINISTRATION STAFF; AVAILABILITY

WASHINGTON, Nov. 17 -- Food and Drug Administration has issued a notice called: Menstrual Products-Performance Testing and Labeling Recommendations; Draft Guidance for Industry and Food and Drug Administration Staff; Availability.

The notice was published in the Federal Register on Nov. 17 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA or Agency) is announcing the availability of the draft guidance entitled "Menstrual Products-Performance Testing and Labeling Recommendations." This draft guidance document provides recommendations for performance testing, labeling, and information for inclusion in premarket notification (510(k)) submissions, when ne...